More than 11,000 researchers, clinicians, patient advocates and drugmakers gathered last week at the San Antonio Breast Cancer Symposium to share the latest treatments, tricks and tools to take down b...

Higher levels of omega-6 fatty acids often found in ultraprocessed foods may interfere with the immune system’s fight against cancer cells, a new study says.

Researchers have discovered how chemotherapy can change tumours, making them more vulnerable to new types of treatments.

Guest post by Mike Linn. Opinions are those of the author. Being a cancer patient is easily the most stressful thing I’ve ever gone through. Combining holiday stress with my diagnosis has been a uniqu...

Disproven health claims are accepted with little challenge by host on number one podcast, BBC investigation finds.

The survey carried out with Cancer Trials Ireland found one in five women cannot pay their monthly bills and 87% face mental illnesses

With Dr. Benedikt Westphalen. Precision oncology offers hope by tailoring cancer treatments to individual molecular and genetic profiles, but how close are we to making it accessible for all? This video explores the challenges and opportunities in scaling precision oncology amidst a global cancer crisis, with 20 million new cases and 10 million deaths annually. Key Discussion Points: 🔬 Challenges: Unequal access to molecular profiling and diagnostics. Limited expertise in interpreting test results. Barriers to accessing targeted therapies. Infrastructure limitations for scaling diagnostics and treatment. 🌟 Opportunities: Harnessing AI and advanced technologies for diagnostics. Integrating genomic testing into standard care practices. Enhancing global collaboration to ensure equal access. Discover how systemic changes, technological innovations, and collaborative efforts could reshape cancer care and unlock the full potential of precision oncology for patients worldwide.

Stéphane Babonneau had to watch thousands of videos of Gisèle Pelicot being raped, before disclosing their horror to her. He explains how she found the courage to cope – and to change the world for other survivors

Cancer registry’s annual report examined variation in incidence and survival over a 10-year period

Characterization of a common germline variant in PCSK9 unveils a hereditary basis underlying breast cancer metastasis and suggests that PCSK9 inhibition therapy could be a promising strategy for breast cancer metastasis prevention.

Sensitivity to chemotherapy is affected by hormonal fluctuations.

The phase 3 SONIA trial challenges the benefits of using cyclin-dependent kinase 4 and 6 inhibitors as a first-line compared with second-line treatment.

I love Christmas. I always have. I love the eggnog, decorating the tree with the silver ornaments my parents gave me as an annual Christmas gift, listening to holiday songs. My daughter was also bo…

Breast cancer is often thought of as a woman’s disease. But men can get breast cancer, too. Breast medical oncologist Sharon Giordano, M.D., shares insights about male breast cancer.

Kate was a busy working Mum of 7 adult kids, who felt in control of her body and her world. Then a breast cancer diagnosis from a routine mammogram shocked and angered her, and set her on a journey to...

Podcast · Heidi Keeling and Mand Black · Imagine being told "you have incurable cancer". How do people 'keep going' despite being told they are dying? This podcast is about cancer, it is about the wi...

For 15 years, they had been the best of friends, with proof of their rapport radiating from our TV screens every day as they sat together on the This Morning sofa.

METAvivor Community Partner, supporting those with metastatic breast cancer through advocacy, awareness, and research funding.

Take this survey powered by surveymonkey.com. Create your own surveys for free.

Pediatric Research - If things were simple, word would have gotten around. Can complexity science help us improve pediatric research?

AbstractBackground. Immune checkpoint inhibitors (ICIs) are associated with severe immune-related adverse events (s-irAEs) that result in hospitalization,

AbstractPurpose:. The treatment efficacy of nivolumab was evaluated in patients with advanced, treatment-refractory solid mismatch repair deficiency/microsatellite-instable (dMMR/MSI) tumors, and in-d...